jag-mosaic-slider-50

Serving a Broad Range of Species

Our products will serve companion animals,
horses and production animals with prescription
and non-prescription products globally.

Neonorm Foal Available Now

jungle-slider

Access to Powerful, Natural Compounds

Jaguar maintains an exclusive, worldwide
license to a large medicinal plant library for
veterinary applications.

Neonorm Foal Available Now
slider-girl-dog3

Committed to Animal Health

We are focused on the development &
commercialization of animal health
solutions that are naturally derived
& sustainably harvested.

Neonorm Foal Available Now
slider-horse

New Anti-Diarrheal Product for Foals
Is your current foal diarrhea product supported
by clinical evidence? (We suspect not)


Naturally derived health solutions for animals around the world

icon-paw-print-60x64

About Us

We’re focused on developing and commercializing a range of first-in-class prescription and non-prescription gastrointestinal products for companion animals, horses and production animals.

icon-paw-print-60x64

Mission

Jaguar is committed to identifying animal health market opportunities where we can develop species-specific products that leverage our broad intellectual property portfolio, deep pipeline and extensive botanical library.

icon-paw-print-60x64

News

May 4, 2016: Jaguar Animal Health Initiates Dose Determination Study with the Target Commercial Paste Formulation of SB-300, the Company’s Drug Product Candidate for Treatment of Equine Gastric Ulcer Syndrome
READ MORE
Apr. 19, 2016: SB-300, Jaguar’s Drug Product Candidate for the Treatment of Gastric Ulcers, Enables Continued Therapy in Performance Horses in Accordance with Standard Testing Guidelines
READ MORE
Apr. 13, 2016: Jaguar Animal Health Obtains Protocol Concurrence From FDA for Canalevia Drug Product Candidate for Treatment of Acute Diarrhea in Dogs
READ MORE

Would you like to receive occasional updates about Jaguar and our products? If so, enter your email address to join our mailing list: